Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.
Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.
Nosocomial infections are increasing rapidly both internationally and domestically,
 especially carbapenem-resistant Klebsiella pneumoniae infections. However, there were still
 lack of evidence about the risk and prognosis in Taiwan. The choice of drug and related
 sensitivity test was also limited. We would analyze the infection risk, prognosis, and drug
 sensitivity of Klebsiella pneumoniae and focus on strategy to manage carbapenem-resistant
 Klebsiella pneumoniae infections.
All adult patients (≥18 years) with K. pneumoniae bloodstream infection were included.
 Patients were excluded if there was other recognized bacteremia within two weeks before or
 after the first episode of K. pneumoniae bloodstream infection.